American Renal Associates Holdings, Inc (ARA) Buy or Sell Stock Guide

Last updated: Yesterday

The analysis below may be helpful to you if you have any of the following questions about ARA stock:

  • Is ARA a buy or a sell?
  • Should I sell or hold ARA stock today?
  • Is ARA a good buy / a good investment?
  • What are ARA analyst opinions, recommendations, ratings?

Here are ARA stock buy reasons/signals:

1. ARA forward P/E ratio is 23.84, and it’s low compared to its industry peers’ P/E ratios.

2. ARA Price/Sales ratio is 0.73, and it’s low compared to its industry peers’ P/S ratios.

3. ARA PEG ratio (P/E adjusted for growth) is 1.50, and it’s low compared to its industry peers’ PEG ratios.

4. ARA average analyst rating is Buy.

Here are ARA stock sell reasons/signals:

1. ARA quarterly revenue growth was -2.70%, lower than the industry and sector average revenue growth (1.69% and 1.69%, respectively).

2. ARA profitability is declining. The YoY profit margin change was -2.94pp.

3. ARA average analyst price target ($17.50) is below its current price ($18.70).

4. ARA short share of float is 24.33%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock.

5. ARA short interest (days to cover the shorts) ratio is 7.32. The stock garners more short interest than the average industry, sector or S&P 500 stock.

What are your thoughts on ARA?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Comments (0)expand_more